Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

102.69
+1.631.61%
Post-market: 102.690.00000.00%19:30 EDT
Volume:458.31K
Turnover:46.77M
Market Cap:4.67B
PE:50.09
High:102.89
Open:101.70
Low:100.53
Close:101.06
52wk High:109.57
52wk Low:47.32
Shares:45.45M
Float Shares:44.60M
Volume Ratio:0.81
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.05
EPS(LYR):2.05
ROE:11.20%
ROA:6.60%
PB:5.58
PE(LYR):50.09

Loading ...

Intellia’s Lonvo-z Gains FDA Priority Review for HAE

TIPRANKS
·
Sep 09

Pharvaris Shares Rise on Positive Results for Hereditary Angioedema Trial

Dow Jones
·
Sep 08

Pharvaris Affirmed as Emerging Oral HAE Leader on Strong Phase 3 Data; Buy Rating Reiterated with Unchanged $60 Price Target

TIPRANKS
·
Sep 08

Pharvaris Unveils CHAPTER-3 Phase 3 Topline Data and HAE Pipeline Milestones

TIPRANKS
·
Sep 08

Pharvaris Posts Strong Phase 3 HAE Prophylaxis Data for Oral Deucrictibant XR

TIPRANKS
·
Sep 08

Pharvaris announces positive topline data from deucrictibant in HAE attacks

TIPRANKS
·
Sep 08

Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks

GlobeNewswire
·
Sep 08

U.S. Research Roundup-Broadcom, Deere & Co, Snowflake

Reuters
·
Sep 03

BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan

GlobeNewswire
·
Aug 25

Haemonetics Price Target Raised to $119.00/Share from $96.00 by Baird

Dow Jones
·
Aug 21

Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating

MT Newswires Live
·
Aug 19

Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma

MT Newswires Live
·
Aug 19

Haemonetics rises 15.2%

TIPRANKS
·
Aug 18

Haemonetics is Maintained at Buy by BTIG

Dow Jones
·
Aug 18

Haemonetics: CSL Plasma Migration Deal Highlights Long-Term Upside but Near-Term Risk/Reward Keeps Rating at Hold

TIPRANKS
·
Aug 18

Haemonetics Corp : Bofa Global Research Raises Price Objective to $120 from $100

THOMSON REUTERS
·
Aug 18

Haemonetics Corp - Enters Supply Agreement with CSL Plasma on August 14, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 18

Haemonetics Corp - CSL May Use Co.'S Nexsys Pcs Devices with Persona Plus Technology & Purchase Related Disposables in U.S. - SEC Filing

THOMSON REUTERS
·
Aug 18

Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables

Reuters
·
Aug 18

Baxter Stock And 2 MedTech Turnaround Plays Retail Investors Are Watching

Simply Wall St.
·
Aug 17